Biocon Stock Soars 4% Following US Market Approval for Yesafili by Subsidiary

Biocon Stock Soars 4% Following US Market Approval…

ByAbhinandanApr 15, 2025

Biocon Biologics Ltd’s shares surged over 4% following a positive…

JOIN US
Image Not Found

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!